摘要
目的:探讨麦默通旋切系统在乳腺临床触诊阴性病灶活检中的应用及意义。方法:通过对我院73例乳腺X线摄影及彩超发现的临床触诊阴性乳腺病灶采用麦默通真空辅助旋切活检及BARD穿刺针活检,分析其病理结果。结果:43例麦默通活检病人及30例BARD穿刺活检病人,其活检成功率分别为100%及83.3%,病理符合率分别为100%及84.6%,两组比较有统计学差异(P<0.05)。早期癌比例麦默通组占16.3%,BARD穿刺针组为6.7%,但尚无统计学差异。结论:麦默通微创活检具有微创、安全的特点,诊断灵敏度及特异度更高,可作为临床触诊阴性乳腺病灶活检的首选方法。
Objective To evaluate the application of Mammotome minimally invasive biopsy（MMIBS） in the diagnosis of non-palpable small lesions with abnormal mammographic and ultrasonographic findings in the breast.Methods A total of 73 patients with non-palpable small breast lesions and abnormal imaging findings were performed by MMIBS or the BARD biopsy needle.The results of pathological diagnosis were analysed.Results The success ratio of samples choosing the Mammotome and the BARD biopsy needle were 100% and 83.3% respectively.The accurate ratio of pathological diagnosis of the Mammotome group was 100%,and that of the BARD biopsy needle group was 84.6%,and the difference was of statistical significance（P0.05）.The ratio of early cancer diagnosis by the Mammotome and by the BARD biopsy needle were 16.3% and 6.7% respectively,which showed no significant difference.Conclusions MMIBS is characterized by producing minimal invasion,safety,high sensitivity and high specificity,and is recommended to be the first choice in the diagnosis of non-palpable small lesions with abnormal imaging findings.
出处
《外科理论与实践》
2011年第1期26-28,共3页
Journal of Surgery Concepts & Practice
